Pancreatic cancer is a tough opponent. It often spreads to nearby blood vessels. Doctors sometimes have to remove part of a vein during surgery to get rid of all the cancer. This is called a venous resection. A recent study looked at how this affects patients with pancreatic ductal adenocarcinoma. The study involved 435 patients. Some had this vein surgery, others d...
In the world of intensive care, not every patient walks out alive. About 16% of patients in ICUs do not survive the treatment. For those on mechanical ventilation or dialysis, the outlook is even grimmer, with only half living beyond six months. Predicting who will pull through is far from an exact science. Time-limited trials, or TLTs, are a tool that can help stee...
Lung cancer is a serious disease that affects many people. In Norway, researchers looked into how different types of advanced non-squamous non-small cell lung cancer (NSCLC) are treated. They focused on patients with specific genetic changes: EGFR+, ALK+, and ROS1+. These genetic changes can make a big difference in how the cancer responds to treatment. The study tr...
In the Southeastern part of the United States, breast cancer is a tough battle, especially for women from low-income backgrounds. Researchers wanted to see if having a strong social network and being religious or spiritual could make a difference in survival rates. They focused on Black and White women, who were mostly from low-income families. The idea was to see i...
Osteosarcoma, a type of bone cancer, affects both kids and adults. But how do their survival rates compare? This question has puzzled researchers for a while. A recent study dug into a huge database to find answers. The main goal was to see if there's a difference in how long patients live after diagnosis. They also wanted to figure out what might affect survival rat...
Treating biliary tract cancer (BTC) is a real challenge. While combining chemotherapy with drugs that target PD-1 protein (called PD-1 inhibitors) might work well, doctors need better ways to predict who will benefit the most. A team at Changzhou First People's Hospital decided to look into this. They studied two groups: one getting chemotherapy alone and another get...
Ovarian cancer has long been known as one of the deadliest gynecological cancers. Despite improvements in diagnosis and treatment, survival rates haven't budged in over three decades. This study dived into the trends and factors linked to ovarian cancer in Indonesia from 1990 to 2021, using data from the Global Burden of Disease project. The goal? To provide insights...
Did you know that how well your lung cancer shrinks after initial treatment can tell a lot about your chances of survival? This is especially true for people with a specific type of lung cancer, called resectable stage IIIA non-small cell lung cancer. Doctors have been wondering if a significant reduction in cancer size, what they call a "major pathologic response, "...
Scientists dived into a registry called J-PVAD to examine how pumping blood out of the left ventricle before restarting blood flow impacts survival in heart attack patients with severe heart dysfunction. They looked at patients treated with an Impella device from February 2020 to December 2021. These patients were divided into groups based on when they started using ...
Colon cancer is a big deal in both China and the United States. But how do these two countries compare when it comes to who gets it, where it hits, and how well people survive? Let's dive in. Over a decade, from 2006 to 2019, the US saw more new cases of colon cancer than China. In China, the cancer often struck guys more than gals (58. 9% vs 41. 1%), and it tended ...